These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 26929032)
1. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores. Esteve-Pastor MA; Marín F; Bertomeu-Martinez V; Roldán-Rabadán I; Cequier-Fillat Á; Badimon L; Muñiz-García J; Valdés M; Anguita-Sánchez M; Intern Med J; 2016 May; 46(5):583-9. PubMed ID: 26929032 [TBL] [Abstract][Full Text] [Related]
2. The association between asymptomatic coronary artery disease and CHADS2 and CHA2 DS2 -VASc scores in patients with stroke. Cha MJ; Lee HS; Kim YD; Nam HS; Heo JH Eur J Neurol; 2013 Sep; 20(9):1256-63. PubMed ID: 23560528 [TBL] [Abstract][Full Text] [Related]
3. CHA Su CH; Tsao TF; Chen AC; Chang KW; Yang YS; Ueng KC; Tsai CF Eur J Clin Invest; 2018 Mar; 48(3):. PubMed ID: 29288496 [TBL] [Abstract][Full Text] [Related]
4. Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey. Brandes A; Overgaard M; Plauborg L; Dehlendorff C; Lyck F; Peulicke J; Poulsen SV; Husted S Clin Cardiol; 2013 Jul; 36(7):427-32. PubMed ID: 23670894 [TBL] [Abstract][Full Text] [Related]
5. Augmented intelligence decision tool for stroke prediction combines factors from CHA Horne BD; Jacobs V; May HT; Graves KG; Bunch TJ J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1452-1461. PubMed ID: 31115939 [TBL] [Abstract][Full Text] [Related]
6. The role of CHADS2 and CHA2 DS2 -VASc scores in the prediction of stroke in individuals without atrial fibrillation: a population-based study. Saliba W; Gronich N; Barnett-Griness O; Rennert G J Thromb Haemost; 2016 Jun; 14(6):1155-62. PubMed ID: 27037960 [TBL] [Abstract][Full Text] [Related]
7. Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2 -VASc score of 1. Huang D; Anguo L; Yue WS; Yin L; Tse HF; Siu CW Pacing Clin Electrophysiol; 2014 Nov; 37(11):1442-7. PubMed ID: 25039724 [TBL] [Abstract][Full Text] [Related]
8. Time trends in use of the CHADS Habboushe J; Altman C; Lip GYH Int J Clin Pract; 2019 Feb; 73(2):e13280. PubMed ID: 30281876 [TBL] [Abstract][Full Text] [Related]
9. [Cardioembolic stroke in atrial fibrillation and new anticoagulation criteria: a therapeutic dare]. Perez-Ortega I; Moniche-Alvarez F; Jimenez-Hernandez MD; Gonzalez-Marcos JR Rev Neurol; 2012 Jul; 55(2):74-80. PubMed ID: 22760766 [TBL] [Abstract][Full Text] [Related]
10. CHADS2 score/CHA2 DS2 -VASc score and major artery occlusion in cardioembolic stroke patients with nonvalvular atrial fibrillation. Deguchi I; Hayashi T; Ohe Y; Kato Y; Fukuoka T; Maruyama H; Horiuchi Y; Sano H; Nagamine Y; Tanahashi N Int J Stroke; 2014 Jul; 9(5):576-9. PubMed ID: 24447527 [TBL] [Abstract][Full Text] [Related]
11. CHA Mlodawska E; Tomaszuk-Kazberuk A; Lopatowska P; Kaminski M; Musial WJ Intern Med J; 2017 Mar; 47(3):275-279. PubMed ID: 27860070 [TBL] [Abstract][Full Text] [Related]
12. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219 [TBL] [Abstract][Full Text] [Related]
13. Comparison between CHADS2 and CHA2 DS2 -VASc score in a stroke cohort with atrial fibrillation. Giralt-Steinhauer E; Cuadrado-Godia E; Ois A; Jiménez-Conde J; Rodríguez-Campello Á; Soriano C; Roquer J Eur J Neurol; 2013 Apr; 20(4):623-8. PubMed ID: 22834861 [TBL] [Abstract][Full Text] [Related]
14. Do CHA2 DS2 VASc and HAS-BLED scores influence 'real-world' anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre. Lopatowska P; Tomaszuk-Kazberuk A; Mlodawska E; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S; Musial WJ Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1297-303. PubMed ID: 26419506 [TBL] [Abstract][Full Text] [Related]
15. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981 [TBL] [Abstract][Full Text] [Related]
16. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk. Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272 [TBL] [Abstract][Full Text] [Related]
17. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809 [TBL] [Abstract][Full Text] [Related]
18. Burden of atrial fibrillation: a retrospective review of patients presenting to acute medical services. Jolliffe E; Fu V; Lanford J; Weatherall M; Rosemergy I Intern Med J; 2016 Oct; 46(10):1166-1171. PubMed ID: 27501863 [TBL] [Abstract][Full Text] [Related]
19. Correlation between cardiac rhythm, left atrial appendage flow velocity, and CHA Zuo K; Sun L; Yang X; Lyu X; Li K Clin Cardiol; 2017 Feb; 40(2):120-125. PubMed ID: 28075503 [TBL] [Abstract][Full Text] [Related]
20. Use of preoperative CHA2 DS2 -VASc score to predict the risk of atrial fibrillation after cardiothoracic surgery: a nested case-control study from the Atrial Fibrillation Suppression Trials (AFIST) I, II, and III. Baker WL; Coleman CI; White CM; Kluger J Pharmacotherapy; 2013 May; 33(5):489-95. PubMed ID: 23649811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]